Toxic epidermal necrosis - Epidermalibus Toxicus Necrosis
https://en.wikipedia.org/wiki/Toxic_epidermal_necrolysis
☆ AI Dermatology — Free ServiceIn anno 2022 Stiftung Warentest ex Germania provenit, satisfactio consumptoria cum ModelDerm paulo minus fuit quam cum consultationibus telemedicinis solutis. relevance score : -100.0%
References
 Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: A Review of Diagnosis and Management 34577817 NIH
Stevens‑Johnson Syndrome (SJS) et Toxic Epidermal Necrolysis (TEN) rarae conditiones sunt, in quibus cutis amplam necrosim et effusionem patitur. In curandis, ciclosporinum maxime efficax est pro SJS, dum coniunctio immunoglobulini intravenosi (IVIg) et corticosteroidorum optime pro casibus SJS et TEN operatur.
Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are rare diseases that are characterized by widespread epidermal necrosis and sloughing of skin. Regarding treatment, cyclosporine is the most effective therapy for the treatment of SJS, and a combination of intravenous immunoglobulin (IVIg) and corticosteroids is most effective for SJS/TEN overlap and TEN.
 Toxic Epidermal Necrolysis: A Review of Past and Present Therapeutic Approaches 36469487Toxic epidermal necrolysis (TEN) gravis reactiones cutis causantur a quibusdam medicamentis et activitate immuna, resultans in extensa detachmente strati exterioris (epidermis), plus quam 30 % superficiei corporis afficiens. TEN habet mortalitatem plus quam viginti %, saepe ob infectiones et difficultates spirandi. Cessare medicamentum quod reactionem provocavit, praebere curam de supportu, et uti curationibus adjunctis ad meliorandum eventum potest. Recentia studia docuerunt medicamenta sicut cyclosporine, TNF‑alpha inhibitors, et combinatio intravenousium immunoglobulinum cum corticosteroides posse esse utiles, fundata in iudiciis moderatis et multiplicibus analysibus studiorum randomizatorum.
Toxic epidermal necrolysis (TEN) is a serious skin reaction caused by certain medications and immune system activity, resulting in large-scale detachment of the outer skin layer (epidermis), affecting more than 30% of the body's surface. TEN has a mortality rate of over 20%, often due to infections and breathing difficulties. Stopping the medication causing the reaction, providing supportive care, and using additional treatments can improve the outcome. Recent studies have shown that drugs like cyclosporine, tumor necrosis factor alpha inhibitors, and a combination of intravenous immune globulin and corticosteroids can be helpful, based on randomized controlled trials and analyses of multiple studies.
 Toxic Epidermal Necrolysis and Steven–Johnson Syndrome: A Comprehensive Review 32520664 NIH
Recent Advances: There is improved understanding of pain and morbidity with regard to the type and frequency of dressing changes. More modern dressings, such as nanocrystalline, are currently favored as they may be kept in situ for longer periods. The most recent evidence on systemic agents, such as corticosteroids and cyclosporine, and novel treatments, are also discussed.
 
Frequentissimae causae sunt quaedam medicamenta, ut lamotrigine, carbamazepine, allopurinol, sulfonamide antibiotic, et nevirapine. Factores periculosi includunt HIV et lupus erythematosus systemicum. Curatio typice praebetur in valetudinariis, ut in unitate combustionis vel unitate intensive curae.
○ Curatio
Gravis hic morbus est; si labia tua vel os afficiuntur vel cutis tua pustulata est, medicum quam primum videas.
Medicamina suspecta suspendenda sunt (v.g. antibiotica, non‑steroidales medicamenta inflammationis anti‑inflammatoriae).